The Recurrent-Specific Regulation Network of Prognostic Stemness-Related Signatures in Low-Grade Glioma
Disease Markers · 2023
DOI: 10.1155/2023/2243928 ↗Kurz gefasst
Fachartikel in der Zeitschrift Disease Markers, 2023. Verfasst von Jin Li und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopedics, The First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China. Hauptthemen laut MEDLINE: Glioma, Brain Neoplasms, Astrocytoma. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Henan Medical Science and Technology, Henan Medical Science and Technology Research Project.
Abstract (Originalsprache)
Gliomas including astrocytomas, oligodendrogliomas, mixed oligoastrocytic, and mixed glioneuronal tumors are an important group of brain tumors. Based on the 2016 WHO classification for tumors in the central nervous system, gliomas were classified into four grades, from I to IV, and brain lower grade glioma (LGG) consists of grade II and grade III. Patients with LGG may undergo recurrence, which makes clinical treatment tough. Stem cell-like features of cancer cells play a key role in tumor’s biological behaviors, including tumorigenesis, development, and clinical prognosis. In this article, we quantified the stemness feature of cancer cells using the mRNA stemness index (mRNAsi) and identified stemness-related key genes based on correlation with mRNAsi. Besides, hallmark gene sets and translate factors (TFs) which were highly related to stemness-related key genes were identified. Therefore, a recurrency-specific network was constructed and a potential regulation pathway was identified. Several online databases, assay for transposase-accessible chromatin using sequencing (ATAC-seq), single-cell sequencing analysis, and immunohistochemistry were utilized to validate the scientific hypothesis. Finally, we proposed that aurora kinase A (AURKA), positively regulated by Non-SMC Condensin I Complex Subunit G (NCAPG), promoted E2F target pathway in LGG, which played an important role in LGG recurrence.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Orthopedics, The First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China.
- Department of Comprehensive Chemotherapy, Hunan Cancer Hospital, 283 Tongzipo Road, Changsha, Hunan, China.
- Tongji University School of Medicine, Shanghai 200092, China.
- Department of Operating Room, Tongji Hospital, School of Medicine, Tongji University, Shanghai 200065, China.
- Department of Orthopaedic Surgery, Changhai Hospital, Navy Military Medical University, Shanghai 200433, China.
- Division of Spine, Department of Orthopedics, Tongji Hospital Affiliated to Tongji University School of Medicine, Shanghai 200065, China.
ORCID-Profile: Runzhi Huang, Enbo Qi, Zongqiang Huang
Förderung
- Henan Medical Science and Technology
- Henan Medical Science and Technology Research Project
Zitieren
APA
Li, J., Zhou, M., Huang, D., Lin, R., Cui, X., Chen, S., Yao, Y., Xian, S., Wang, S., Fu, Q., Zhu, J., Yue, X., Huang, R., Qi, E., & Huang, Z. (2023). The Recurrent-Specific Regulation Network of Prognostic Stemness-Related Signatures in Low-Grade Glioma. Disease Markers. https://doi.org/10.1155/2023/2243928
Vancouver
Li J, Zhou M, Huang D, Lin R, Cui X, Chen S, et al. The Recurrent-Specific Regulation Network of Prognostic Stemness-Related Signatures in Low-Grade Glioma. Disease Markers. 2023. doi:10.1155/2023/2243928
BibTeX
@article{Li2023,
author = {Li, Jin and Zhou, Meng and Huang, Dan and Lin, Ruoyi and Cui, Xiaomei and Chen, Shaofeng and Yao, Ying and Xian, Shuyuan and Wang, Siqiao and Fu, Qing and Zhu, Jiwen and Yue, Xi and Huang, Runzhi and Qi, Enbo and Huang, Zongqiang},
title = {The Recurrent-Specific Regulation Network of Prognostic Stemness-Related Signatures in Low-Grade Glioma},
journal = {Disease Markers},
year = {2023},
doi = {10.1155/2023/2243928}
}
EUVIMED